Read more about GSK says it aims to bring FDA-approved antibody therapy to India for Covid on Business Standard. Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.
Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.